Role of Interleukin 5 Inhibition in the Treatment of Eosinophilic Otitis Media.

Nathaniel K Breslin, N Hadley Heindel,Rex S Haberman

OTO open（2021）

引用 4|浏览0

暂无评分

摘要

EOM is a rare disease that otolaryngologists should include in their differential diagnosis, especially in refractory cases. Anti-IL-5 agents show efficacy in treating EOM, and prospective multicenter clinical trials are needed to further characterize the effect of anti-IL-5 therapies.

查看译文

关键词

biologic therapy,chronic otitis media,eosinophilic otitis media

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要